Hospital
Arkansas Childrens Northwest, INC.
Arkansas Childrens Northwest, INC. was paid $48.08M by Medicaid between Apr 2018 and Dec 2024, across 258 billing codes. Its largest line is 87633, Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets — 28% of everything it billed.
33Billing provider infoARKANSAS CHILDRENS NORTHWEST, INC.
SPRINGDALE, AR 72762
SPRINGDALE, AR 72762
33aNPI1255875746assigned 12/19/2016
33bProvider typeChildren's Hospital
28Total paid$48.08M
24GClaims1,020,038
24DCodes billed258
24AFirst – last monthApr 2018 – Dec 2024
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 47,104 | $828K | |
| 2019 | 102,282 | $3.58M | |
| 2020 | 102,548 | $4.48M | |
| 2021 | 151,359 | $7.97M | |
| 2022 | 192,215 | $10.28M | |
| 2023 | 220,969 | $11.01M | |
| 2024incomplete | 203,561 | $9.92M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 28% | 55,789 | 48,204 | $13.53M |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 8.4% | 55,881 | 48,262 | $4.05M |
| T1015 | A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive | 6.0% | 189,888 | 151,610 | $2.89M |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 4.9% | 15,115 | 12,877 | $2.34M |
| 87581 | 4.8% | 55,735 | 48,235 | $2.31M | |
| 87486 | 4.8% | 55,717 | 48,225 | $2.31M | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | 3.6% | 3,209 | 2,907 | $1.75M |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 2.5% | 19,584 | 17,527 | $1.18M |
| J0585 | Injection, onabotulinumtoxina, 1 unit | 2.1% | 275 | 220 | $1.02M |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 2.0% | 3,184 | 2,852 | $958K |
| 70450 | Computed tomography, head or brain; without contrast material | 1.5% | 3,684 | 3,257 | $739K |
| 93303 | Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study | 1.3% | 4,229 | 3,685 | $641K |
246 more codes
| 80053 | Comprehensive metabolic panel | 1.3% | 31,468 | $614K |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | 1.2% | 1,421 | $587K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 1.1% | 6,998 | $505K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 32,672 | $466K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 19,470 | $465K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 4,673 | $432K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 5,570 | $396K |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | <1% | 1,453 | $387K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 535 | $356K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 799 | $341K |
| 84145 | <1% | 10,161 | $306K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 9,349 | $304K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 1,130 | $287K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 3,915 | $243K |
| 76770 | <1% | 4,551 | $237K | |
| 74019 | <1% | 7,663 | $227K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 10,294 | $222K |
| 87631 | <1% | 1,548 | $221K | |
| 93320 | <1% | 4,229 | $218K | |
| 95819 | <1% | 2,106 | $197K | |
| 84439 | <1% | 10,768 | $197K | |
| 80050 | General health panel | <1% | 2,721 | $197K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 9,607 | $196K |
| 80061 | Lipid panel | <1% | 6,165 | $186K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 12,978 | $173K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 6,713 | $164K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 289 | $164K |
| 90686 | <1% | 9,104 | $160K | |
| 86140 | <1% | 18,184 | $154K | |
| 85027 | <1% | 16,602 | $154K | |
| 72141 | <1% | 244 | $143K | |
| 94010 | <1% | 4,777 | $141K | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 305 | $136K |
| 92587 | <1% | 2,663 | $133K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 5,241 | $123K |
| 87040 | <1% | 8,148 | $123K | |
| 82728 | <1% | 4,686 | $121K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 8,688 | $119K |
| 92611 | <1% | 2,510 | $114K | |
| 74022 | <1% | 2,885 | $108K | |
| 74018 | <1% | 3,623 | $103K | |
| 97162 | <1% | 575 | $101K | |
| 72082 | <1% | 1,510 | $101K | |
| 81003 | <1% | 23,143 | $90K | |
| 85055 | <1% | 3,158 | $90K | |
| 42830 | <1% | 257 | $89K | |
| 92567 | <1% | 5,446 | $86K | |
| 93325 | <1% | 4,558 | $79K | |
| 74230 | <1% | 2,557 | $77K | |
| 72170 | <1% | 2,517 | $76K | |
| 73630 | <1% | 1,823 | $75K | |
| 80306 | <1% | 1,952 | $74K | |
| 85007 | <1% | 15,170 | $73K | |
| 0072A | <1% | 493 | $67K | |
| 72146 | <1% | 91 | $67K | |
| 81025 | <1% | 4,745 | $64K | |
| 0071A | <1% | 498 | $63K | |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 3,421 | $58K |
| 82803 | <1% | 1,469 | $58K | |
| 90670 | <1% | 5,316 | $58K | |
| 73590 | <1% | 2,120 | $55K | |
| 73090 | <1% | 2,559 | $55K | |
| 83690 | <1% | 4,172 | $54K | |
| 90647 | <1% | 4,561 | $54K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 821 | $54K |
| 76376 | <1% | 2,106 | $53K | |
| 73610 | <1% | 2,205 | $52K | |
| 90651 | <1% | 2,130 | $51K | |
| 76536 | <1% | 877 | $51K | |
| 87077 | <1% | 3,171 | $47K | |
| 83735 | <1% | 4,340 | $47K | |
| 81001 | <1% | 8,740 | $46K | |
| 73562 | <1% | 1,045 | $46K | |
| 90633 | <1% | 3,990 | $45K | |
| 90723 | <1% | 4,155 | $45K | |
| 95812 | <1% | 354 | $45K | |
| 80069 | <1% | 2,696 | $45K | |
| 0001A | <1% | 569 | $45K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 3,157 | $43K |
| 82948 | <1% | 5,978 | $43K | |
| 90619 | <1% | 605 | $43K | |
| 82977 | <1% | 3,005 | $42K | |
| 73130 | <1% | 1,089 | $41K | |
| 93975 | <1% | 337 | $41K | |
| 83550 | <1% | 2,212 | $37K | |
| 73080 | <1% | 1,663 | $37K | |
| 84703 | <1% | 2,534 | $36K | |
| 90681 | <1% | 3,171 | $35K | |
| 73110 | <1% | 1,102 | $34K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 672 | $33K |
| 87186 | <1% | 3,015 | $33K | |
| 82248 | <1% | 3,977 | $32K | |
| 85652 | <1% | 5,878 | $32K | |
| 77073 | <1% | 664 | $31K | |
| 80076 | <1% | 1,679 | $31K | |
| 83540 | <1% | 2,323 | $30K | |
| 93225 | <1% | 544 | $30K | |
| 84100 | <1% | 3,868 | $30K | |
| 90710 | <1% | 2,571 | $30K | |
| 0081A | <1% | 278 | $28K | |
| 90715 | <1% | 1,337 | $28K | |
| 85046 | <1% | 3,055 | $28K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 86 | $25K |
| 0002A | <1% | 251 | $24K | |
| 70250 | <1% | 604 | $22K | |
| 85610 | <1% | 2,909 | $22K | |
| 77072 | <1% | 601 | $22K | |
| 76885 | <1% | 462 | $21K | |
| 84460 | <1% | 2,278 | $21K | |
| 90700 | <1% | 1,796 | $21K | |
| 87506 | <1% | 73 | $21K | |
| 72081 | <1% | 545 | $20K | |
| 82962 | <1% | 3,516 | $19K | |
| 83525 | <1% | 747 | $19K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 145 | $19K |
| 90734 | <1% | 970 | $19K | |
| 76870 | <1% | 456 | $19K | |
| 87088 | <1% | 1,794 | $19K | |
| 0082A | <1% | 175 | $17K | |
| 73552 | <1% | 789 | $17K | |
| 90696 | <1% | 1,369 | $17K | |
| 87807 | <1% | 1,438 | $16K | |
| 73100 | <1% | 676 | $16K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,273 | $16K |
| 73070 | <1% | 890 | $16K | |
| 90697 | <1% | 1,160 | $16K | |
| 85730 | <1% | 1,522 | $15K | |
| 73140 | <1% | 677 | $15K | |
| 82247 | <1% | 2,939 | $15K | |
| A9575 | Injection, gadoterate meglumine, 0.1 ml | <1% | 299 | $15K |
| 86901 | <1% | 473 | $15K | |
| 87505 | <1% | 80 | $14K | |
| 83615 | <1% | 1,585 | $14K | |
| 82550 | <1% | 1,276 | $14K | |
| 0124A | <1% | 211 | $13K | |
| 91320 | <1% | 139 | $13K | |
| 82330 | <1% | 513 | $13K | |
| 87070 | <1% | 1,242 | $13K | |
| 82375 | <1% | 509 | $12K | |
| 97001 | <1% | 327 | $12K | |
| 92582 | <1% | 1,531 | $12K | |
| 83605 | <1% | 562 | $11K | |
| 82150 | <1% | 921 | $11K | |
| 80051 | <1% | 751 | $11K | |
| 73564 | <1% | 253 | $11K | |
| 90671 | <1% | 1,180 | $11K | |
| J9370 | Vincristine sulfate, 1 mg | <1% | 268 | $11K |
| 73030 | <1% | 380 | $9K | |
| 92523 | <1% | 232 | $9K | |
| 90656 | <1% | 496 | $8K | |
| 44970 | <1% | 30 | $8K | |
| 70360 | <1% | 746 | $8K | |
| 82810 | <1% | 446 | $8K | |
| 51798 | <1% | 35 | $8K | |
| 82565 | <1% | 1,188 | $8K | |
| 90707 | <1% | 624 | $8K | |
| 93976 | <1% | 75 | $7K | |
| 72100 | <1% | 185 | $7K | |
| 82947 | <1% | 892 | $7K | |
| 84295 | <1% | 903 | $7K | |
| 82374 | <1% | 839 | $7K | |
| 90716 | <1% | 612 | $7K | |
| 84132 | <1% | 889 | $7K | |
| 70486 | <1% | 27 | $6K | |
| 84550 | <1% | 891 | $6K | |
| 90688 | <1% | 692 | $6K | |
| 0054A | <1% | 186 | $6K | |
| 80143 | <1% | 173 | $6K | |
| 91319 | <1% | 126 | $6K | |
| 71045 | Radiologic examination, chest; single view | <1% | 429 | $6K |
| 77080 | <1% | 25 | $6K | |
| 83050 | <1% | 522 | $6K | |
| 94060 | <1% | 97 | $6K | |
| 85018 | <1% | 1,663 | $6K | |
| 92555 | <1% | 1,826 | $5K | |
| Q3014 | Telehealth originating site facility fee | <1% | 1,479 | $5K |
| 92552 | <1% | 914 | $5K | |
| 0154A | <1% | 138 | $5K | |
| 93242 | <1% | 352 | $5K | |
| 72040 | <1% | 118 | $5K | |
| 87205 | <1% | 980 | $5K | |
| 76882 | <1% | 372 | $5K | |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | <1% | 2,523 | $5K |
| 71020 | <1% | 339 | $5K | |
| 91318 | <1% | 184 | $4K | |
| 95816 | <1% | 86 | $4K | |
| 82570 | <1% | 477 | $4K | |
| 73000 | <1% | 237 | $4K | |
| 85014 | <1% | 908 | $4K | |
| 83880 | <1% | 59 | $4K | |
| 73560 | <1% | 126 | $4K | |
| 90677 | <1% | 283 | $4K | |
| 80179 | <1% | 91 | $3K | |
| 92556 | <1% | 670 | $3K | |
| 82010 | <1% | 168 | $3K | |
| 54161 | <1% | 14 | $3K | |
| 86308 | <1% | 293 | $3K | |
| 82043 | <1% | 248 | $3K | |
| 94664 | <1% | 789 | $2K | |
| 74020 | <1% | 134 | $2K | |
| 92553 | <1% | 346 | $2K | |
| 89051 | <1% | 390 | $2K | |
| 82077 | <1% | 65 | $2K | |
| 97165 | <1% | 12 | $2K | |
| 86900 | <1% | 479 | $2K | |
| 84156 | <1% | 301 | $2K | |
| 87015 | <1% | 249 | $2K | |
| 90381 | <1% | 121 | $2K | |
| 84450 | <1% | 138 | $1K | |
| 93978 | <1% | 15 | $1K | |
| 72070 | <1% | 50 | $1K | |
| 84484 | <1% | 62 | $1K | |
| 86850 | <1% | 265 | $1K | |
| 94760 | <1% | 56 | $1K | |
| 73620 | <1% | 33 | $1K | |
| 82270 | <1% | 234 | $989.45 | |
| 82945 | <1% | 250 | $974.13 | |
| 85384 | <1% | 88 | $916.78 | |
| 74000 | <1% | 57 | $907.72 | |
| 84157 | <1% | 250 | $906.54 | |
| 83970 | <1% | 12 | $875.85 | |
| 80164 | <1% | 24 | $854.81 | |
| 93226 | <1% | 13 | $830.00 | |
| 76010 | <1% | 107 | $818.06 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 64 | $789.20 |
| 90380 | <1% | 94 | $788.40 | |
| 0083A | <1% | 13 | $636.40 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 228 | $532.03 |
| 90732 | <1% | 47 | $505.36 | |
| 84520 | <1% | 52 | $393.49 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 55 | $374.40 |
| 84702 | <1% | 39 | $359.59 | |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | <1% | 946 | $341.19 |
| A9276 | Sensor; invasive (e.g., subcutaneous), disposable, for use with non-durable medical equipment interstitial continuous glucose monitoring system, one unit = 1 day supply | <1% | 1,096 | $259.03 |
| 85379 | <1% | 14 | $253.55 | |
| J2704 | Injection, propofol, 10 mg | <1% | 116 | $210.98 |
| 76000 | 0% | 90 | $0.00 | |
| E0445 | Oximeter device for measuring blood oxygen levels non-invasively | 0% | 561 | $0.00 |
| A4565 | Slings | 0% | 14 | $0.00 |
| 92595 | 0% | 15 | $0.00 | |
| A7046 | Water chamber for humidifier, used with positive airway pressure device, replacement, each | 0% | 12 | $0.00 |
| V5275 | Ear impression, each | 0% | 56 | $0.00 |
| 92558 | 0% | 60 | $0.00 | |
| 85008 | 0% | 86 | $0.00 | |
| 99214 | Doctor's office visit, returning patient (more involved) | 0% | 58 | $0.00 |
| 99213 | Doctor's office visit, returning patient (routine) | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialPHILLIPS, SHERYL (SR. BILLING MANAGER)
Parent organizationARKANSAS CHILDRENS, INC.
| Provider | Location | Paid |
|---|---|---|
| Arkansas Childrens Hospital | Little Rock, AR | $154.95M |
| Angel One Arkansas Children's Hospital | Little Rock, AR | $20.06M |
| Arkansas Childrens Hospital | Little Rock, AR | $6.93M |
| Arkansas Children's Hospital | Little Rock, AR | $810K |
| Arkansas Children's Hospital | Little Rock, AR | $65K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.